Pharmacist's Plea: Kidney Dialysis Patients Received Misbranded Drugs
Topeka, Kan. - A pharmacist from Tennessee has pleaded guilty to substituting a cheaper drug imported from China for the iron sucrose that the Federal Drug Administration has approved for kidney dialysis patients, U.S. Attorney Barry Grissom said today. The misbranded drug was administered to kidney dialysis patients in Kansas.
Action Details
- Date:May 21, 2013
- Agency:U.S. Attorney
-
Enforcement Types:
- Criminal and Civil Actions